Back to search

Intralesional Infusion of Lymphokine-activated Killer (LAK) Cells and Recombinant Interleukin-2 (rIL-2) for the Treatment of Patients with Malignant Brain Tumor

Data up to Jan 2025

Published1988
Citations93
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Intralesional Infusion of Lymphokine-activated Killer (LAK) Cells and Recombinant… (1988) – Neurosurgery | Metascience Observatory Explorer